{"id":"https://openalex.org/W2012228144","doi":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","title":"Reductions in Stavudine Dose Might Ameliorate Mitochondrial-Associated Complications Without Compromising Antiviral Activity","display_name":"Reductions in Stavudine Dose Might Ameliorate Mitochondrial-Associated Complications Without Compromising Antiviral Activity","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-01","ids":{"openalex":"https://openalex.org/W2012228144","doi":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","mag":"2012228144","pmid":"https://pubmed.ncbi.nlm.nih.gov/16214736"},"language":"en","primary_location":{"id":"doi:10.1310/ed57-eu48-rk6a-e5u0","doi":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","is_oa":true,"landing_page_url":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1310/ED57-EU48-RK6A-E5U0?needAccess=true&role=button","source":{"id":"https://openalex.org/S13415641","display_name":"HIV Clinical Trials","issn_l":"1528-4336","issn":["1528-4336","1945-5771"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV Clinical Trials","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012228144"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1310/ED57-EU48-RK6A-E5U0?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024454544","display_name":"Matilde S\u00e1nchez\u2010Conde","orcid":"https://orcid.org/0000-0003-3880-199X","observed_orcids":["https://orcid.org/0000-0003-3880-199X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matilde S\u00e1nchez-Conde","raw_affiliation_strings":["Department of Infectious Diseases, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019171058","display_name":"Carmen de Mendoza","orcid":"https://orcid.org/0000-0001-5224-7492","observed_orcids":["https://orcid.org/0000-0001-5224-7492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmen de Mendoza","raw_affiliation_strings":["Department of Infectious Diseases, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105935726","display_name":"Inmaculada Jim\u00e9nez\u2010N\u00e1cher","orcid":"https://orcid.org/0000-0002-0680-5534","observed_orcids":["https://orcid.org/0000-0002-0680-5534"]},"institutions":[{"id":"https://openalex.org/I4387152292","display_name":"Carlos III Hospital","ror":"https://ror.org/05ntpq911","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746","https://openalex.org/I4387152292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Inmaculada Jim\u00e9nez-Nacher","raw_affiliation_strings":["Service of PharmacyHospital Carlos III, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of PharmacyHospital Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I4387152292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003553956","display_name":"Pablo Barreiro","orcid":"https://orcid.org/0000-0002-3819-5371","observed_orcids":["https://orcid.org/0000-0002-3819-5371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pablo Barreiro","raw_affiliation_strings":["Department of Infectious Diseases, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074827235","display_name":"Juan Gonz\u00e1lez\u2010Lahoz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Gonzalez-Lahoz","raw_affiliation_strings":["Department of Infectious Diseases, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009751300","display_name":"Vincent Soriano","orcid":"https://orcid.org/0000-0002-4624-5199","observed_orcids":["https://orcid.org/0000-0002-4624-5199"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Vincent Soriano","raw_affiliation_strings":["Department of Infectious Diseases, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009751300"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1323,"has_fulltext":true,"cited_by_count":40,"citation_normalized_percentile":{"value":0.85549688,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"4","first_page":"197","last_page":"202"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0478999987244606,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.7919999957084656},{"id":"https://openalex.org/keywords/mitochondrial-toxicity","display_name":"mitochondrial toxicity","score":0.9909999966621399},{"id":"https://openalex.org/keywords/mitochondrial-dna-depletion","display_name":"mitochondrial DNA depletion","score":0.8140000104904175},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7419999837875366},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/lipodystrophy","display_name":"lipodystrophy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/lipoatrophy","display_name":"lipoatrophy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.8849999904632568},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.9225845336914062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.826404333114624},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.6385304927825928},{"id":"https://openalex.org/C2777071529","wikidata":"https://www.wikidata.org/wiki/Q12796879","display_name":"Mitochondrial toxicity","level":3,"score":0.6302891969680786},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5955405831336975},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5828924179077148},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5601222515106201},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5240497589111328},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.4465838074684143},{"id":"https://openalex.org/C2992092908","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug toxicity","level":3,"score":0.4272798001766205},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4073907434940338},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3962269425392151},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.33365926146507263},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.3157578110694885},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3037947416305542},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.26273855566978455},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.23585885763168335},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12491372227668762},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09565475583076477},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004272","descriptor_name":"DNA, Mitochondrial","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1310/ed57-eu48-rk6a-e5u0","doi":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","is_oa":true,"landing_page_url":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1310/ED57-EU48-RK6A-E5U0?needAccess=true&role=button","source":{"id":"https://openalex.org/S13415641","display_name":"HIV Clinical Trials","issn_l":"1528-4336","issn":["1528-4336","1945-5771"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV Clinical Trials","raw_type":"journal-article"},{"id":"pmid:16214736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16214736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV clinical trials","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1310/ed57-eu48-rk6a-e5u0","doi":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","is_oa":true,"landing_page_url":"https://doi.org/10.1310/ed57-eu48-rk6a-e5u0","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1310/ED57-EU48-RK6A-E5U0?needAccess=true&role=button","source":{"id":"https://openalex.org/S13415641","display_name":"HIV Clinical Trials","issn_l":"1528-4336","issn":["1528-4336","1945-5771"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV Clinical Trials","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307875","display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","ror":"https://ror.org/01fn7me06"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2012228144.pdf","grobid_xml":"https://content.openalex.org/works/W2012228144.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W33919623","https://openalex.org/W300744380","https://openalex.org/W1529467507","https://openalex.org/W1974902143","https://openalex.org/W2008681391","https://openalex.org/W2013831846","https://openalex.org/W2016336666","https://openalex.org/W2024720867","https://openalex.org/W2033271256","https://openalex.org/W2044877337","https://openalex.org/W2048496837","https://openalex.org/W2050999867","https://openalex.org/W2054620412","https://openalex.org/W2058299739","https://openalex.org/W2076562284","https://openalex.org/W2084332399","https://openalex.org/W2109812415","https://openalex.org/W2117579170","https://openalex.org/W2120231058","https://openalex.org/W2127970905","https://openalex.org/W2141163306","https://openalex.org/W2161533339","https://openalex.org/W2164075000","https://openalex.org/W2321323882","https://openalex.org/W2334153995","https://openalex.org/W2411004043","https://openalex.org/W2428240338","https://openalex.org/W2916542119","https://openalex.org/W3201385391","https://openalex.org/W4241628799"],"related_works":["https://openalex.org/W2435567028","https://openalex.org/W2047995333","https://openalex.org/W2168665142","https://openalex.org/W2010095385","https://openalex.org/W2089071370","https://openalex.org/W2185180256","https://openalex.org/W2004211910","https://openalex.org/W2186789484","https://openalex.org/W1529467507"],"abstract_inverted_index":{"BACKGROUND:":[0],"Stavudine":[1],"(d4T)":[2],"is":[3],"a":[4,69,90,209,229],"nucleoside":[5],"analogue":[6],"approved":[7],"for":[8,80,161],"the":[9,26,40,44,60,81,98,110,115,129,145,173,198,216,236,250,267,271],"treatment":[10],"of":[11,43,63,95,100,123,138,182,213,231,270,280],"HIV":[12,75],"infection.":[13],"Concern":[14],"has":[15],"risen":[16],"due":[17],"to":[18,87,104,255],"its":[19,48],"association":[20],"with":[21,114],"mitochondrial":[22,217,281],"toxicity.":[23],"Given":[24],"that":[25],"toxicity":[27,282],"might":[28,38],"be":[29,288],"dose-dependent,":[30],"we":[31],"explored":[32],"prospectively":[33],"whether":[34],"lowering":[35],"d4T":[36,101,117,199,237,251],"doses":[37],"improve":[39],"safety":[41],"profile":[42],"drug":[45],"without":[46,186,265],"compromising":[47,266],"antiviral":[49,268],"activity.":[50],"METHOD:":[51],"All":[52],"HIV-infected":[53],"patients":[54,96,125,140,183,233],"seen":[55],"at":[56,169,184],"our":[57],"institution":[58],"during":[59,144],"first":[61],"semester":[62],"year":[64],"2003":[65],"who":[66,234],"were":[67,85,126,159,195],"receiving":[68],"d4T-containing":[70],"regimen":[71],"and":[72,109,133,151,167,191],"had":[73],"plasma":[74],"RNA":[76],"below":[77],"50":[78],"copies/mL":[79],"previous":[82],"3":[83],"months":[84,206,292],"invited":[86],"participate":[88],"in":[89,92,128,180,197,215,220,228,243,249,263,284],"trial":[91],"which":[93],"half":[94,112],"reduced":[97,235],"dose":[99,118,252],"from":[102,253],"40":[103,254],"30":[105,200,256],"mg":[106,201,257],"bid":[107,202,258],"(cases)":[108],"other":[111],"continued":[113],"same":[116],"(controls).":[119],"RESULTS:":[120],"A":[121,136,247],"total":[122,137],"92":[124],"recruited":[127],"study:":[130],"47":[131],"cases":[132,150],"45":[134],"controls.":[135,153,245],"9":[139],"experienced":[141],"virological":[142],"failure":[143],"following":[146],"12":[147,205,291],"months:":[148],"4":[149],"5":[152],"No":[154],"significant":[155,187,193,211,274],"differences":[156,188],"between":[157,189],"groups":[158],"recognized":[160,179,196,227,289],"mean":[162],"transaminase":[163],"levels,":[164],"cholesterol,":[165],"triglycerides,":[166],"lactate":[168],"baseline":[170],"nor":[171],"over":[172,290],"12-month":[174],"follow-up":[175],"period.":[176],"Lipodystrophy":[177],"was":[178,226],"20%":[181],"baseline,":[185],"groups,":[190],"no":[192],"improvements":[194,275],"arm":[203],"after":[204],"follow-up.":[207,293],"However,":[208,273],"median":[210],"increase":[212],"2.23-fold":[214],"DNA":[218],"content":[219],"peripheral":[221],"blood":[222],"mononuclear":[223],"cells":[224],"(PBMCs)":[225],"subset":[230],"11":[232],"dose,":[238],"whereas":[239],"it":[240],"remained":[241],"unchanged":[242],"10":[244],"CONCLUSION:":[246],"reduction":[248],"may":[259],"ameliorate":[260],"mtDNA":[261],"depletion":[262],"PBMCs":[264],"activity":[269],"drug.":[272],"on":[276],"surrogate":[277],"laboratory":[278],"markers":[279],"or":[283],"lipoatrophy":[285],"could":[286],"not":[287]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012228144","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
